Jon Winkelried and 2 Others Sells $145M of LifeStance Health Group Inc (LFST) — SEC Form 4, Mar 04, 2026
Open-Market Net Sale · SEC Form 4
−$145,002,278
Equity position changed by -12.9%
Reporting Owners
10%+
10%+
10%+
TXN 2026-03-02
·
FILED 2026-03-04
Equity Position
140M sh
160,711,618 → 140,026,557
Equity Change
-12.9%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owners
| Name | Relationship |
|---|---|
| Jon Winkelried CIK 0001366946 |
10% Owner
|
| Tpg Gp A, LLC CIK 0001903793 |
10% Owner
|
| James G Coulter CIK 0001099776 |
10% Owner
|
Jon Winkelried at LifeStance Health Group Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$742,969,593
More from this insider at LifeStance Health Group Inc
| 2026-09-15 | Sell | -$226,255,274 | View |
| 2026-08-12 | Sell | -$144,890,858 | View |
| 2026-05-14 | Sell | -$226,821,183 | View |
| 2024-05-29 | Sell | -$85,843,814 | View |
Non-Derivative Securities Transactions
Footnotes (3)
- F1
- Each of James G. Coulter and Jon Winkelried own entities that control TPG GP A, LLC (together with Messrs. Coulter and Winkelried, the "Reporting Persons"), which exercises direct or indirect control over entities that collectively hold 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., which is the sole member of TPG GPCo, LLC, which is the sole member of TPG Holdings II-A, LLC, which is the general partner of TPG Operating Group II, L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Operating Group I, L.P., which is the sole member of TPG GenPar VIII Advisors, LLC, which is the general partner of TPG GenPar VIII, L.P., which is the general partner of TPG VIII Lynnwood Holdings Aggregation, L.P. ("TPG VIII Lynnwood"), which directly holds 140,026,557 shares of Common Stock of LifeStance Health Group, Inc. Show more
- F2
- Because of the relationship between the Reporting Persons and TPG VIII Lynnwood, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of TPG VIII Lynnwood. Each of TPG VIII Lynnwood and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of TPG VIII Lynnwood's or such Reporting Person's pecuniary interest therein, if any. Show more
- F3
- Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Show more
Remarks
(4) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (5) Gerald Neugebauer is signing on behalf of Messrs. Coulter and Winkelried pursuant to authorization and designation letters dated January 10, 2024, which were previously filed with the Securities and Exchange Commission.
Show moreRelated filings at LifeStance Health Group Inc
Institutional Holders
13F holders · Jun 30, 2026
290
institutional managers reporting a position
Largest by reported value
- Tpg Gp A, Llc $1.2B
- Fmr Llc $624M
- Black Rock, Inc. $389M
5%+ Holders · 13D/G
4 filers
-
Black Rock, Inc. 10.1%
-
Tpg Gp A, Llc 25.7%
-
Summit Partners L P 6.1%
-
Fmr Llc 15.0%
Other insiders at LifeStance Health Group Inc
GET /v1/forms/4/0001999371-26-005046
API docs
View Original SEC Filing